Alzheimer Disease and Associated Disorders
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.6 | Q3 | 37.8% | 0.485 | Q2 | 59.9% |
| 2024 | 1.4 | Q3 | 36.7% | 0.685 | Q2 | 72.9% |
| 2023 | 1.8 | Q3 | 41.0% | 0.609 | Q2 | 71.5% |
| 2022 | 2.1 | Q3 | 42.9% | 0.676 | Q2 | 75.7% |
| 2021 | 2.4 | Q3 | 43.4% | 0.880 | Q1 | 83.7% |
| 2020 | — | — | 1.213 | Q1 | 89.1% | |
| 2019 | — | — | 1.152 | Q1 | 88.5% | |
| 2018 | — | — | 1.086 | Q1 | 86.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1546-4156
ISSN
0893-0341
country
UScoverage
1987-2026